Cardurion

is a Massachusetts-based biotechnology company that researches and develops novel therapeutics for the treatment of cardiovascular diseases...
Read more
Cardurion President & CEO: Peter S. Lawrence

President & CEO

Peter S. Lawrence

CEO Approval Rating

88/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$603.6M

Cardurion Competitors

1XyloCor
2Tenaya
3Lexeo
4CinCor
5Cytokinetics
6MyoKardia
7Renova Therapeutics
8Esperion
9Gemphire Therapeutics
10XBiotech

Trending Companies